SCHEMBL4285371

SCHEMBL4285371

CC(Oc1ccccc1)(C(=O)C(F)(F)F)N1CCCCC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2B6 P20813 1/20 0.41
EPHX2 P34913 1/20 0.38
CHRM3 P20309 6/20 0.38
GAA P10253 2/20 0.38
SMN1; SMN2 Q16637 4/20 0.37
LMNA P02545 2/20 0.37
HPGD P15428 2/20 0.37
NPC1 O15118 2/20 0.37
RAB9A P51151 2/20 0.37
TP53 P04637 1/20 0.37
THRB P10828 1/20 0.37
KDM4E B2RXH2 2/20 0.36
MAPT P10636 2/20 0.36
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
PDK1 Q15118 1/20 0.35
PDK2 Q15119 1/20 0.35
PDK3 Q15120 1/20 0.35
PDK4 Q16654 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4285375 0.74 HPGD (0.38) CYP2B6EPHX2CHRM3GAASMN1; SMN2
SCHEMBL8827475 0.72 CES1 (0.43) GAA
SCHEMBL4285382 0.71 GAA (0.50) EPHX2GAASMN1; SMN2LMNAHPGD
SCHEMBL23903305 0.70 ALDH1A1 (0.50) EPHX2GAASMN1; SMN2LMNAHPGD
SCHEMBL30608899 0.68 CYP2B6 (0.43) CYP2B6CHRM3MAPTMEN1KMT2A
SCHEMBL9680992 0.67 ALDH1A1 (0.51) CYP2B6GAASMN1; SMN2LMNANPC1
SCHEMBL10634257 0.66 CES1 (0.41) EPHX2MAPTMEN1KMT2AALDH1A1
SCHEMBL25442179 0.66 KMT2A (0.45) EPHX2GAASMN1; SMN2LMNAHPGD
SCHEMBL11204803 0.66 PPARG (0.46) KDM4EMAPTMEN1KMT2APDK1
SCHEMBL9680403 0.65 HPGD (0.52) CYP2B6GAASMN1; SMN2LMNAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2069300-A2 MULTIMEDIATOR TRANSPORTER INHIBITORS FOR USE IN TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS PREXA PHARMACEUTICALS, INC. (US) 2009-06-17 EP disclosed
WO-2008024371-A2 MULTIMEDIATOR TRANSPORTER INHIBITORS FOR USE IN TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS PREXA PHARMACEUTICALS, INC. (US) 2008-02-28 WO disclosed